A systematic review on different treatment methods of bone metastasis from cancers

Chinese Journal of Lung Cancer

Volumn 13, Issue 5, 2010, Pages 533-539

  Ren, Yaoyao ^a,b   Ma, Li ^b   Tian, Jinhui ^a   Zhang, Linlin ^b   Yang, Kehu ^a  

^a LANZHOU UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Bisphosphonates; Bone metastasis; Radiotherapy; Systematic review

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ANALGESIA; ARTICLE; BONE METASTASIS; CANCER RADIOTHERAPY; CLINICAL TRIAL; DRUG SAFETY; FEVER; HUMAN; NEOPLASM; QUALITY OF LIFE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

BONE NEOPLASMS; COMBINED MODALITY THERAPY; DIPHOSPHONATES; HUMANS; QUALITY OF LIFE;

EID: 77952868868     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2010.05.28     Document Type: Article

References (30)

1. Riccio AI, Wodajo FM, Malawer M. Metastatic carcinoma of the long bones. Am Fam Physician, 2007, 76(10): 1489-1494.
2. Rubens F. Bone metastases. In: Langlais F, Tomeno B, Limb S eds. Major Reconstruction in ocologic and nontumoral conditions. New York: Springer, 1991, 121-142.
3. Rosen LS, Gordon D, Kamlnski M, et al. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial. Cancer J, 2001, 7(5): 377-387.
4. Johns JR, Williams G, Pazdur R. End points and united states food and drug administration approval of oncology drugs. J Clin Oncol, 2003, 21(7): 1401-1411.
5. Furukawa M, Ohta T, Xiong Y. Activation of UBC5 ubiquitin-conjugating enzyme by the RING finger of ROC1 and assembly of active ubiquitin ligases by all cullins. J Biol Chem, 2002, 277(18): 15758-15765. (Pubitemid 34967851)
6. Ning ZH, Pei HL, Huang J, et al. Combined therapy of radiotherapy and zoledronic acid in patients with bone metastases pain. J Mod Oncol, 2007, 15(12): 1843-1846.
7. Yin F, Zhang Q. Combined therapy of radiotherapy and ibandronic acid vs radiotherapy alone in patients with bone metastases pain. Clin Focus, 2007, 22(20): 1504-1505.
8. Zuo LH. Clinical analysis of 90 cases of radiotherapy plus pamidronate for pain of bone metastasis. Chin Commun Doctors, 2004, 17(6): 25.
9. Zheng ZH, Zhang Y. Radiotherapy plus Pamidronate for bone metastasis. Chin Commun Doctors, 2003, 18(2): 27-28.
10. Zeng QB, Wang CX. Pamidronate plus radiotherapy vs radiotherapy alone for bone metastasis. Public Enterprise Med J, 2005, 18(3): 44.
11. Wang MZ, Yang KH, Liu AN, et al. Clinical efficacy for radiotherapy plus zoledronic acid hydrate in the treatment of bone metastases. Chin Hospital Harm J, 2006, 26(10): 1267-1268.
12. Miao ZH, Lu P. Combined therapy of radiotherapy and ibandronic acid in patients with bone metastases pain. Clin Focus, 2004, 19(12): 705-706.
13. Lu SP, Zheng Q, Yu X. Pamidronate plus Radiotherapy for bone meatstasis pain. Central Plains Med J, 2003, 30(23): 26.
14. Liu L, Lu H, Ding Q. Ibandronic acid plus radiotherapy for bone metastasis. Cancer Res Prev Treat, 2005, 32(3): 185.
15. Liu DG, Hang C, Li BS, et al. Therapeutic effect of combination of radiotherapy with ibandronate in bone metastases. Chin J Clin Oncol, 2004, 31(7): 398-401.
16. Liang GH, Tian SW, Wu JH. Ibandronic acid plus radiotherapy for bone metastasis. J Mod Oncol, 2005, 13(6): 817-818.
17. Jiang QJ. Combined therapy of pamidronate and radiotherapy for bone metastasis. J Jinzhou Med College, 2001, 22(2): 43-44.
18. Chen JM, Yang JS, Guo ML. Ibandronic acid plus radiotherapy for bone metastasis. J Basic Clin Oncol, 2007, 20(4): 347.
19. Zhao HY, Qiu XJ, Wang Y, et al. Clinical analysis of 34 cases of radiotherapy plus zoledronic acid for pain of bone metastasis. J Nantong Med College, 2006, 26(6): 498-499.
20. Li ZY, Ma QT, Ren X, et al. Combined therapy of zledronic acid and radiotherapy for bone metastasis. Sichuan J Cancer Control, 2006, 19(3): 208-209.
21. Ren Q, Yu JH, Wu X. Combined therapy of pamidronate and radiotherapy for bone metastasis. Chin Clin Oncol, 2006, 11(7): 545-546.
22. Shi JG, Huang YD, Yang HB, et al. The effect of sodium ibandranate injection combined with radiotherapy and single radiotherapy for the patients with multimatastatic carcinoma of bone. Mod Oncol, 2006, 14(4): 478-479.
23. Cao H, Shan S, Zhou G, et al. Clinical study of metastatic bone tumour treated with zoledronic acid combined with radiotherapy. Chin J Pain Med, 2006, 12(1): 14-17.
24. Gong LP, Zhang Y. Clinical study on improvement of life quality of late-stage breast cancer patients with bone metastasis treated with ibandronate injection combined with radiotherapy and chemotherapy. Chin J Clin Oncol Rehabil, 2005, 12(6): 573-575.
25. Chen ZH, Yu ZH, Li HM, et al. Clinical study of metastatic bone tumour treated with pamidronate and combined with radiotherapy. Sichuan J Cancer Control, 2002, 15(4): 200-202.
26. Li L, Cen DC, He Y. Pamidronate plus radiotherapy vs radiotherapy alone for bone metastasis. Chin Commun Doctors, 2002, 18(17): 31-32.
27. Zhou YF, Xiao WQ, Zhang XM, et al. Combined therapy of pamidronate and radiotherapy for bone metastasis. J Pract Oncol, 2000, 14(1): 30-32.
28. Mehrotra B. Safety profile of intravenous bisphosphonates. Semin Oncol, 2007, 34(6 Suppl 4): 24-27.
29. Goblirsch M, Lynch C, Mathews W, et al. Radiation treatment decreases bone cancer pain through direct effect on tumor cells. Radiat Res, 2005, 164(4 Pt 1): 400-408. (Pubitemid 41368948)
30. Dewar JA. Managing metastatic bone pain. BMJ, 2004, 329(7470): 812-813.